Cat. No. 5273
Chemical Name: (6E)-6,7,8,9-Tetradeoxy-N-[(3S,6S)-
Biological ActivityPotent inhibitor of NF-κB activation (IC50 = 85 nM); decreases IκBα phosphorylation. Attenuates LPS-induced nitric oxide production and expression of TNF-α, IL-6 and MCP. Suppresses proliferation of HeLa and HCT116 cells. Anti-inflammatory and antitumor.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Johnson et al (2012) Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC-MS/ELSD libraries. Bioorg.Med.Chem. 20 4348. PMID: 22705020.
Hu et al (2007) Regulation of c-Src nonreceptor tyrosine kinase activity by bengamide A through inhibition of methionine aminopeptidases. Chem.Biol. 14 764. PMID: 17656313.
Kinder et al (2001) Synthesis and antitumor activity of ester-modified analogues of bengamide B. J.Med.Chem. 44 3692. PMID: 11606134.
If you know of a relevant reference for Bengamide B please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Bengamide B from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Bengamide B, supplier, Methionyl, aminopeptidase, MetAP1, MetAP2, potent, NF-κB, inhibitors, nuclear, factor, kappa, B, anti-inflammatory, antitumor, antitumour, inhibits, Tocris Bioscience, NF-κB and IκB Inhibitor products
Find multiple products by catalog number
New Products in this Area
Receptor for advanced glycation end products (RAGE) antagonistGaliellalactone
STAT3 inhibitor; active in vivoCP 424174
Inhibitor of IL-1β post-translational processing; indirectly inhibits NLRP3IT 901
NF-κB c-Rel subunit inhibitor
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.